Cargando…

Medicinal Herbs and Their Active Compounds for Fatty Liver Diseases

Detalles Bibliográficos
Autores principales:	Son, Chang Gue, Wei, Zhang, Raghavendran, H. Balaji, Wang, Jing-Hua, Janda, Elzbieta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738570/ https://www.ncbi.nlm.nih.gov/pubmed/29362587 http://dx.doi.org/10.1155/2017/3612478

Ejemplares similares

Complementary and Alternative Medicine for Diseases and Disorders in Digestive Tract: Basic to Clinics
por: Son, Chang Gue, et al.
Publicado: (2013)

Multiple Bioactivities of Traditional Medicinal Herbs for Treatment of Neurodegenerative Diseases
por: Park, Gunhyuk, et al.
Publicado: (2018)

Current knowledge on alleviating Helicobacter pylori infections through the use of some commonly known natural products: bench to bedside
por: Murali, Malliga Raman, et al.
Publicado: (2014)

Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine
por: Zhou, Zhijia, et al.
Publicado: (2022)

Beneficial effects of Chinese herbs in the treatment of fatty liver diseases
por: Panyod, Suraphan, et al.
Publicado: (2020)

Cynanchum atratum Alleviates Non-Alcoholic Fatty Liver by Balancing Lipogenesis and Fatty Acid Oxidation in a High-Fat, High-Fructose Diet Mice Model
por: Wang, Jing-Hua, et al.
Publicado: (2021)

Fatty acid variability in three medicinal herbs of Panax species
por: Zhang, Xiao-Jing, et al.
Publicado: (2013)

Risk levels of herb-induced liver injury in Korea: from a meta-analysis
por: Lee, Nam-Hun, et al.
Publicado: (2021)

Metabolic-associated Fatty Liver Disease
por: Zheng, Ming-Hua
Publicado: (2021)

Prediction Methods of Herbal Compounds in Chinese Medicinal Herbs
por: Han, Ke, et al.
Publicado: (2018)

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
por: Jung, Han Na, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Evaluation of the Medicinal Herb Graptopetalum paraguayense as a Treatment for Liver Cancer
por: Hsu, Wei-Hsiang, et al.
Publicado: (2015)

Can metabolomic signature foster precision medicine approaches in nonalcoholic fatty liver disease arena?
por: Lonardo, Amedeo
Publicado: (2022)

Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury
por: Jing, Jing, et al.
Publicado: (2017)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Glutamine, fatty liver disease and aging
por: Simón, Jorge, et al.
Publicado: (2021)

Chinese Medicinal Herbs Targeting the Gut–Liver Axis and Adipose Tissue–Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science
por: Zhang, Shuwei, et al.
Publicado: (2020)

A nationwide study of the incidence rate of herb-induced liver injury in Korea
por: Cho, Jung-Hyo, et al.
Publicado: (2017)

Hepatoprotective Effect of Herb Formula KIOM2012H against Nonalcoholic Fatty Liver Disease
por: Park, Hwayong, et al.
Publicado: (2015)

Antioxidant activity and hepatoprotective effect of 10 medicinal herbs on CCl(4)-induced liver injury in mice
por: Meng, Xiao, et al.
Publicado: (2020)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

Editorial: The Metabolic (Dysfunction) Associated Fatty Liver Disease (MAFLD)-Non-Alcoholic Fatty Liver Disease (NAFLD) Debate: A Forced Consensus and The Risk of a World Divide
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2022)

Handbook of medicinal herbs /
por: Duke, James A., 1929-
Publicado: (2002)

Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
por: Han, Eugene
Publicado: (2022)

Fatty Liver Disease: Metabolic, Genetic, or Both?
por: Zoller, Heinz, et al.
Publicado: (2020)

Diet and Lifestyle in Nonalcoholic Fatty Liver Disease
por: Martínez-Beamonte, Roberto, et al.
Publicado: (2020)

Implications of comorbidities in nonalcoholic fatty liver disease
por: Song, Sherlot Juan, et al.
Publicado: (2023)

The Potential of Lamiaceae Herbs for Mitigation of Overweight, Obesity, and Fatty Liver: Studies and Perspectives
por: Diab, Farah, et al.
Publicado: (2022)

Panax ginseng Modulates Cytokines in Bone Marrow Toxicity and Myelopoiesis: Ginsenoside Rg1 Partially Supports Myelopoiesis
por: Raghavendran, Hanumantha Rao Balaji, et al.
Publicado: (2012)

From NAFLD to MAFLD: a “redefining” moment for fatty liver disease
por: Zheng, Kenneth I., et al.
Publicado: (2020)

Perspectives of herbs and their natural compounds, and herb formulas on treating diverse diseases through regulating complicated JAK/STAT signaling
por: Chen, Jian-Yu, et al.
Publicado: (2022)

Drug, Herb, and Dietary Supplement Hepatotoxicity
por: Teschke, Rolf, et al.
Publicado: (2016)

Controversial ayurvedic herbs
por: Dixit, V. K.
Publicado: (2011)

Medicinal herbs: Potential polypills in cardiovascular diseases
por: Noroozi, Samaneh, et al.
Publicado: (2021)

Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
por: Valenzuela-Vallejo, Laura, et al.
Publicado: (2023)

Fatty liver in lean patients: is it a different disease?
por: Verdelho Machado, Mariana, et al.
Publicado: (2012)

Nonalcoholic Fatty Liver Disease: Its Mechanisms and Complications
por: El Ouaamari, Abdelfattah, et al.
Publicado: (2013)

Noninvasive Markers for the Diagnosis of Nonalcoholic Fatty Liver Disease
por: Kim, Sang Yong
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5sedrihq0u1h5obhavtln5adfj